This ruling does not change Sandoz's exposure in the multi-state generic drug price-fixing litigation. The case continues; monitor for trial dates, settlement discussions, or further summary judgment motions that may affect Sandoz directly.
Price Chart
Executive Summary
The court partially granted and partially denied summary judgment for defendant Douglas Boothe, a former Perrigo executive, in the multi-state generic drug price-fixing antitrust litigation. Sandoz is a co-defendant but was not directly affected by this ruling, which concerns only Boothe's personal liability. The ruling allows some claims against Boothe to proceed to trial on certain drugs, but does not alter Sandoz's own exposure in the case.
Court Ruling Details
Key Facts
- Ruling on summary judgment for defendant Douglas Boothe (former Perrigo executive) in Connecticut et al v. Sandoz, Inc. et al.
- Motion granted in part and denied in part; Boothe faces trial on claims related to Clindamycin, Desonide ointment (post-July 2013), Econazole (2014 price increase), Fluocinonide, and Halobetasol (2013 price increase and customer allocation).
- Sandoz is a named co-defendant but the ruling does not address Sandoz's own liability or dismiss any claims against it.
- No damages awarded, no injunction issued, and no direct financial impact on Sandoz from this procedural ruling.
Financial Impact
No direct financial impact on Sandoz from this ruling; the case continues with Sandoz still facing antitrust allegations.
Risk Factors
- Ongoing antitrust litigation risk; potential for adverse verdict or settlement if Sandoz is found liable.
- The ruling allows some claims against a co-defendant to proceed, which may increase pressure on all defendants to settle.
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-6be118a2cf-SDZ |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | Court Ruling | — | awaiting T+20 | — | — |
Oct 7, 2026 20d ago | Court Ruling | — | awaiting T+20 | — | — |
Sep 30, 2026 27d ago | Court Ruling | — | awaiting T+20 | — | — |
Sep 30, 2026 27d ago | Court Ruling | — | awaiting T+20 | — | — |
Sep 11, 2026 6w ago | Court Ruling | — | awaiting T+20 | — | — |
Aug 12, 2026 10w ago | Court Ruling | — | awaiting T+20 | — | — |
Aug 6, 2026 11w ago | Court Ruling | — | awaiting T+20 | — | — |
Jul 22, 2026 13w ago | Court Ruling | — | awaiting T+20 | — | — |
Jul 8, 2026 15w ago | Court Ruling | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers